McKesson Corporation (MCK) stock price

McKesson Corporation (MCK) is a Healthcare · Medical Distribution company listed on NYSE. Price $875.91 (-0.42%), Market cap $90.72B, P/E ratio 19.65, 52-week low–high $659.01 ~ $995.69.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical s

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for McKesson Corporation are updated in real time on BlackAll Trade.

McKesson Corporation financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current McKesson Corporation (MCK) stock price?

McKesson Corporation trades at $875.91 (-0.42%). Real-time quotes and charts are available on BlackAll Trade.

What is the McKesson Corporation (MCK) market cap?

McKesson Corporation has a market cap of about $90.72B. Its P/E ratio is 19.65.

What does McKesson Corporation (MCK) do?

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Te